Prevalence of high-risk human papillomavirus among older women

Obstetrics and Gynecology

Volumn 112, Issue 5, 2008, Pages 979-989

  Lindau, Stacy Tessler ^a   Drum, Melinda L ^b   Gaumer, Elyzabeth ^b   Surawska, Hanna ^b   Jordan, Jeanne A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; COMMUNITY; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENOTYPE; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYBRIDIZATION; HYSTERECTOMY; INTERVIEW; INVERSE POLYMERASE CHAIN REACTION; MAJOR CLINICAL STUDY; MARRIAGE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SELF EVALUATION; SEXUAL BEHAVIOR; VAGINA; VIRUS INFECTION; WART VIRUS; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; CROSS-SECTIONAL STUDY; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVALENCE;

AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 58149286557     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31818b0df2     Document Type: Article

References (39)

1. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepi-thelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
2. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
3. Ries LA, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER cancer statistics review, 1975-2003. Bethesda (MD): National Cancer Institute; 2006.
4. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005;23: 1107-22.
5. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillo-mavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
6. Schiffman M, Kjaer SK. Chapter 2: natural history of anogeni-tal human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003;14-9.
7. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006;119:2677-84.
8. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7: 453-9.
9. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191:1808-16.
10. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180: 1415-23.
11. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005;191:182-92.
12. U. S. Census Bureau. U. S. interim projections by age, sex, race, and Hispanic origin, 2004. Available at: http://www. census.gov/ipc/www/ usinterimproj. Retrieved December 6, 2006.
13. Lindau ST, Schumm P, Laumann EO, Levinson W, O'Muircheartaigh C, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-74.
14. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:1157-61.
15. Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24 suppl:S52-61.
16. Merrill RM, Layman AB, Oderda G, Asche C. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol 2008;18:253-60.
17. Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 2007;34:471-85.
18. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
19. Taylor JO, Wallace RB, Ostfeld AM, Blazer DG. Established populations for epidemiologic studies of the elderly, 1981-1993: [East Boston, Massachusetts, Iowa and Washington Counties, Iowa, New Haven, Connecticut, and North Central North Carolina]. Resource Data Book and Questionnaires, ICPSR 9915; 1994.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
21. Qato D, Schumm P, Johnson M, Lindau ST. The National Social Life, Health and Aging Project technical report on medication coding. The University of Chicago and NORC 2007; Available at: http://biomarkers.uchicago.edu/pdfs/ TR-PharmData.pdf. Retrieved September 11, 2008.
22. Lindau ST, Surawska H, Schwartz J, Jordan JA. Vaginal swab measurement of human papillomavirus in Wave I of the National Social Life, Health and Aging Project. The University of Chicago and NORC 2008. Available at: http://biomarkers. uchicago.edu/pdfs/TR-HPV.pdf. Retrieved September 11, 2008.
23. Binder DA. On the variances of asymptotically normal estimators from complex surveys. Int Stat Rev 1983;51:279-92.
24. National Centers for Health Statistics. Analytic and reporting guidelines. In: National Centers for Health Statistics Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports. Hyattsville (MD): U. S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1996.
25. Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodriguez AC, Bratti MC, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006;66:1218-24.
26. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118: 201-10.
27. U. S. Census Bureau. Monthly population estimates by age, sex, race and Hispanic origin for the United States: April 1, 2000 to July 1, 2006. Available at: http://www.census.gov/ popest/national/asrh/2006-nat-ni.html. Retrieved June 27, 2007.
28. Gravitt PE, Lacey JV Jr, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, et al. Evaluation of self-collected cervico-vaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001;10:95-100.
29. Castle PE, Schiffman M, Glass AG, Rush BB, Scott DR, Wacholder S, et al. Human papillomavirus prevalence in women who have and have not undergone hysterectomies. J Infect Dis 2006;194:1702-5.
30. Smith EM, Ritchie JM, Levy BT, Zhang W, Wang D, Haugen TH, et al. Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detect Prev 2003;27: 472-80.
31. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillo-mavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
32. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica J Infect Dis 2005;191:1796-807.
33. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
34. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005;97:577-86.
35. Garcia-Pineres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmetlla I, et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 2006;66:11070-6.
36. Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, Hutchinson ML, et al. A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis 2004;190:458-67.
37. Anderson JE, McCormick L, Fichtner R. Factors associated with self-reported STDs: data from a national survey. Sex Transm Dis 1994;21:303-8.
38. Fenton KA, Johnson AM, McManus S, Erens B. Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect 2001;77:84-92.
39. Fleurence RL, Dixon JM, Milanova TF, Beusterien KM. Review of the economic and quality-of-life burden of cervical human papillomavirus disease. Am J Obstet Gynecol 2007; 196:206-12.